CCRB Logo

Trial History Detail on 2017-01-20

CUHK_CCT00443

2015-01-20

Prospective

CRE-2014.509

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong

Nil

Not Applicable

TSE Lai Yiu

1/F, Block F, Department of Obstetrics &Gynaecology, Prince of Wales Hospital

26321764

eristse@cuhk.edu.hk

Department of Obstetrics &Gynaecology, Prince of Wales Hospital

Hong Kong

Dr. Grace Kong

1/F, Block F, Department of Obstetrics &Gynaecology, Prince of Wales Hospital

2632 2996

gracekong@cuhk.edu.hk

Department of Obstetrics &Gynaecology, Prince of Wales Hospital

Hong Kong

Evaluation of Anti-Mullerian Hormone as a predictive marker in ovarian reserve and assisted reproductive technology

Evaluation of Anti-Mullerian Hormone as a predictive marker in ovarian reserve and assisted reproductive technology

評估以AMH作為預測卵巢功能和輔助生殖技術中卵巢反應的指標

Nil

Hong Kong

Yes

2014-11-11

Joint CUHK-NTEC Clinical Research Ethics Committee

CRE-2014.509

women undergoing IVF cycles

Other

blood takeing

5 ml of blood will be collected for AMH test.

NA

NA

5 mins.

nil

nil

NA

NA

NA

Na

infertility women who attend Assisted Reproductive Technology centre, Prince of Wales Hospital for In-vitro fertilization (IVF) programme

patients who are unwilling to participate

18

45

Female

Observational

Not Applicable

Uncontrolled

Open label

Parallel

Other

NA

2015-02-01

200

Recruiting

To determine the efficacy of AMH to predict the poor ovarian responder and over ovarian responder.

To study the relationship between AMH and the ovarian response after ovarian stimulation in IVF cycle
To study the relationship between AMH and other baseline ovarian reserve markers on assessing the ovarian reserve and ovarian response in IVF cycle

No

2020-07-06

ChiCTR-OOC-15005867 

2015-01-23

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.